Pradaxa vs. Coumadin
See how Pradaxa and Coumadin compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Pradaxa is a fixed twice-daily dose with no routine blood testing, while Coumadin is a once-daily dose adjusted using regular INR blood tests.
Both drugs lower stroke risk in atrial fibrillation and treat blood clots, but only Coumadin is approved for people with mechanical heart valves.
Coumadin has decades of use and a much lower typical list price, while Pradaxa has fewer diet and drug interactions but costs more out of pocket.
Pradaxa vs. Coumadin Drug Summary
Pradaxa
Pradaxa (dabigatran) is a direct thrombin inhibitor, a newer class of blood thinner that does not require routine blood testing. It is FDA-approved to lower stroke risk in atrial fibrillation, to treat and prevent recurrent blood clots (DVT and PE), and to prevent clots after hip replacement surgery. It is a capsule taken twice daily at a fixed dose based on kidney function.
Coumadin
Coumadin (warfarin) is a vitamin K antagonist, one of the oldest blood thinners still widely prescribed. It is FDA-approved to treat and prevent blood clots, lower stroke risk in atrial fibrillation, and protect people with mechanical heart valves. It is a tablet taken once daily, with the dose adjusted based on regular blood tests.
Pradaxa vs. Coumadin Side Effects
Pradaxa
Coumadin
Pradaxa vs. Coumadin Dosage
Pradaxa
Coumadin
| STAGE | DOSE | WHEN |
| Starting dose | 150 mg twice daily | At the start |
| Maximum dose | 75 mg twice daily | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 2 to 5 mg once daily | Days 1-5 |
| Maximum dose | 2 to 5 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Pradaxa
| STAGE | DOSE | WHEN |
| Starting dose | 150 mg twice daily | At the start |
| Maximum dose | 75 mg twice daily | If needed |
| Dose changes | 1 increase | As tolerated |
Coumadin
| STAGE | DOSE | WHEN |
| Starting dose | 2 to 5 mg once daily | Days 1-5 |
| Maximum dose | 2 to 5 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Pradaxa vs. Coumadin Indications
Pradaxa
Pradaxa is approved to lower stroke risk in people with nonvalvular atrial fibrillation, and to treat or reduce the risk of recurrent deep vein thrombosis and pulmonary embolism. It is also approved to prevent blood clots after hip replacement surgery. It is not recommended for people with mechanical heart valves.
Reduce stroke and systemic embolism risk in nonvalvular AFib
Treat deep vein thrombosis and pulmonary embolism
Reduce risk of recurrent DVT or PE
Prevent DVT and PE after hip replacement surgery
Coumadin
Coumadin is approved to treat and prevent venous blood clots and pulmonary embolism, and to lower stroke risk in atrial fibrillation. It is also approved for people with mechanical heart valves and to reduce the risk of death or another heart attack after a myocardial infarction. It has been used for these purposes for over 70 years.
Treat and prevent venous thrombosis and pulmonary embolism
Reduce stroke risk in atrial fibrillation
Prevent clots in mechanical heart valves
Reduce death and recurrent MI risk after a heart attack
Pradaxa vs. Coumadin Pros and Cons
Pradaxa
Pradaxa avoids the routine blood draws and dietary restrictions that come with warfarin, and has a specific reversal agent for emergencies. It costs significantly more than warfarin without insurance and is not an option for people with mechanical heart valves.
Pros
No routine blood testing needed to guide dosing
Few food interactions; dietary vitamin K does not affect it
Specific reversal agent (idarucizumab) available for emergencies
Fixed dosing not affected by genetic differences in metabolism
Cons
Costs roughly $400 to $530 per month brand-name, without insurance
Not recommended for people with mechanical heart valves
Must be taken twice a day, every day, without missed doses
Dose must be adjusted or avoided with significant kidney impairment
Coumadin
Coumadin requires regular INR blood tests and careful attention to vitamin K intake and other drug interactions to stay in a safe range. It is inexpensive and has decades of real-world use, and remains the standard oral option for mechanical heart valves.
Pros
Roughly $40 to $100 per month without insurance, much cheaper than Pradaxa
Approved for people with mechanical heart valves
Decades of clinical experience across many patient types
Effect can be reversed with vitamin K if needed
Cons
Requires regular blood draws to monitor INR levels
Many food and drug interactions, especially vitamin K-rich foods
Genetic differences can make dosing harder to predict
Narrow safe range between too little and too much drug
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.